{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:53:43Z","timestamp":1789386823897,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00259-015-3080-z","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T13:06:02Z","timestamp":1431522362000},"page":"1666-1673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Appearance of untreated bone metastases from breast cancer on FDG PET\/CT: importance of histologic subtype"],"prefix":"10.1007","volume":"42","author":[{"given":"Brittany Z.","family":"Dashevsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana D.","family":"Corben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine S.","family":"Jochelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford A.","family":"Hudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Ulaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"3080_CR1","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","volume":"22","author":"T Hamaoka","year":"2004","unstructured":"Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942\u201353.","journal-title":"J Clin Oncol"},{"key":"3080_CR2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","volume":"16","author":"GN Hortobagyi","year":"1998","unstructured":"Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. J Clin Oncol. 1998;16:2038\u201344.","journal-title":"J Clin Oncol"},{"key":"3080_CR3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0959-8049(97)10128-9","volume":"34","author":"RD Rubens","year":"1998","unstructured":"Rubens RD. Bone metastases \u2013 the clinical problem. Eur J Cancer. 1998;34:210\u20133.","journal-title":"Eur J Cancer"},{"key":"3080_CR4","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","volume":"16","author":"GJ Cook","year":"1998","unstructured":"Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375\u20139.","journal-title":"J Clin Oncol"},{"key":"3080_CR5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/RLU.0b013e3181a7d03c","volume":"34","author":"V Huyge","year":"2009","unstructured":"Huyge V, Garcia C, Vanderstappen A, Alexiou J, Gil T, Flamen P. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET. Clin Nucl Med. 2009;34:417\u201320.","journal-title":"Clin Nucl Med"},{"key":"3080_CR6","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2214\/ajr.184.4.01841266","volume":"184","author":"T Uematsu","year":"2005","unstructured":"Uematsu T, Yuen S, Yukisawa S, Aramaki T, Morimoto N, Endo M, et al. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR Am J Roentgenol. 2005;184:1266\u201373.","journal-title":"AJR Am J Roentgenol"},{"key":"3080_CR7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00259-006-0141-3","volume":"33","author":"O Israel","year":"2006","unstructured":"Israel O, Goldberg A, Nachtigal A, Militianu D, Bar-Shalom R, Keidar Z, et al. FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy. Eur J Nucl Med Mol Imaging. 2006;33:1280\u20134.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3080_CR8","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2007.11.2854","volume":"25","author":"Y Du","year":"2007","unstructured":"Du Y, Cullum I, Illidge TM, Ell PJ. Fusion of metabolic function and morphology: sequential [18F] fluorodeoxyglucose positron-emission tomography\/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. J Clin Oncol. 2007;25:3440\u20137.","journal-title":"J Clin Oncol"},{"key":"3080_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiol.2471070567","volume":"247","author":"U Tateishi","year":"2008","unstructured":"Tateishi U, Gamez C, Dawood S, Yeung HW, Cristofanilli M, Macapinlac HA. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET\/CT. Radiology. 2008;247:189\u201396.","journal-title":"Radiology"},{"key":"3080_CR10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00259-005-1842-8","volume":"32","author":"T Nakai","year":"2005","unstructured":"Nakai T, Okuyama C, Kubota T, Yamada K, Ushijima Y, Taniike K, et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2005;32:1253\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3080_CR11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1699-0463.1988.tb05296.x","volume":"96","author":"H Tulinius","year":"1988","unstructured":"Tulinius H, Bjarnason O, Sigvaldason H, Bjarnadottir G, Olafsdottir G. Tumours in Iceland. 10. malignant tumours of the female breast. a histological classification, laterality, survival and epidemiological considerations. APMIS. 1988;96:229\u201338.","journal-title":"APMIS"},{"key":"3080_CR12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00432-012-1365-1","volume":"139","author":"A Caldarella","year":"2013","unstructured":"Caldarella A, Buzzoni C, Crocetti E, Bianchi S, Vezzosi V, Apicella P, et al. Invasive breast cancer: a significant correlation between histological types and molecular subgroups. J Cancer Res Clin Oncol. 2013;139:617\u201323.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3080_CR13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","volume":"93","author":"CI Li","year":"2005","unstructured":"Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93:1046\u201352.","journal-title":"Br J Cancer"},{"key":"3080_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/rg.291085100","volume":"29","author":"JK Lopez","year":"2009","unstructured":"Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics. 2009;29:165\u201376.","journal-title":"Radiographics"},{"key":"3080_CR15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1148\/radiol.2333031484","volume":"233","author":"WA Berg","year":"2004","unstructured":"Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830\u201349.","journal-title":"Radiology"},{"key":"3080_CR16","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","volume":"18","author":"N Avril","year":"2000","unstructured":"Avril N, Rose CA, Schelling M, Dose J, Kuhn W, Bense S, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol. 2000;18:3495\u2013502.","journal-title":"J Clin Oncol"},{"key":"3080_CR17","first-page":"9","volume":"42","author":"N Avril","year":"2001","unstructured":"Avril N, Menzel M, Dose J, Schelling M, Weber W, Janicke F, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med. 2001;42:9\u201316.","journal-title":"J Nucl Med"},{"key":"3080_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.20.2.379","volume":"20","author":"R Bos","year":"2002","unstructured":"Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, et al. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 2002;20:379\u201387.","journal-title":"J Clin Oncol"},{"key":"3080_CR19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","volume":"29","author":"A Buck","year":"2002","unstructured":"Buck A, Schirrmeister H, Kuhn T, Shen C, Kalker T, Kotzerke J, et al. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging. 2002;29:1317\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3080_CR20","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Update. J Clin Oncol. 2013;31:3997\u20134013.","journal-title":"J Clin Oncol"},{"key":"3080_CR21","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2214\/AJR.13.11156","volume":"202","author":"H He","year":"2014","unstructured":"He H, Gonzalez A, Robinson E, Yang WT. Distant metastatic disease manifestations in infiltrating lobular carcinoma of the breast. AJR Am J Roentgenol. 2014;202:1140\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"3080_CR22","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1200\/JCO.2009.27.5743","volume":"28","author":"PG Morris","year":"2010","unstructured":"Morris PG, Lynch C, Feeney JN, Patil S, Howard J, Larson SM, et al. Integrated positron emission tomography\/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer. J Clin Oncol. 2010;28:3154\u20139.","journal-title":"J Clin Oncol"},{"key":"3080_CR23","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1200\/JCO.2008.17.1496","volume":"26","author":"D Fuster","year":"2008","unstructured":"Fuster D, Duch J, Paredes P, Velasco M, Munoz M, Santamaria G, et al. Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography\/computed tomography compared with conventional imaging procedures. J Clin Oncol. 2008;26:4746\u201351.","journal-title":"J Clin Oncol"},{"key":"3080_CR24","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2967\/jnumed.111.093864","volume":"52","author":"D Groheux","year":"2011","unstructured":"Groheux D, Giacchetti S, Espie M, Vercellino L, Hamy AS, Delord M, et al. The yield of 18F-FDG PET\/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study. J Nucl Med. 2011;52:1526\u201334.","journal-title":"J Nucl Med"},{"key":"3080_CR25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/cam4.119","volume":"2","author":"GA Ulaner","year":"2013","unstructured":"Ulaner GA, Eaton A, Morris PG, Lilienstein J, Jhaveri K, Patil S, et al. Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer. Cancer Med. 2013;2:725\u201333.","journal-title":"Cancer Med"},{"key":"3080_CR26","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1002\/cncr.27579","volume":"118","author":"PG Morris","year":"2012","unstructured":"Morris PG, Ulaner GA, Eaton A, Fazio M, Jhaveri K, Patil S, et al. Standardized uptake value by positron emission tomography\/computed tomography as a prognostic variable in metastatic breast cancer. Cancer. 2012;118:5454\u201362.","journal-title":"Cancer"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3080-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3080-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3080-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T21:52:33Z","timestamp":1651960353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3080-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3080-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}